Eurofins-Cerep (XPAR:ALECR) Valuation Rank

View and export this data going back to 2010. Start your Free Trial

What is Eurofins-Cerep Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Eurofins-Cerep Valuation Rank Related Terms

Thank you for viewing the detailed overview of Eurofins-Cerep's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurofins-Cerep Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins-Cerep SA (XPAR:ALECR) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Le bois l Eveque, Celle l Evescault, FRA, 86600

Website

http://www.cerep.fr

Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.